Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021

BACKGROUND: Oral HIV pre-exposure prophylaxis (PrEP) has been available and fully reimbursed for people at high risk of sexually acquired HIV infection in France since January 2016. Its dissemination has been widely promoted to reduce HIV incidence in high-risk populations. This study aimed to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Billioti de Gage, Sophie, Desplas, David, Dray-Spira, Rosemary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386455/
https://www.ncbi.nlm.nih.gov/pubmed/35990255
http://dx.doi.org/10.1016/j.lanepe.2022.100486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386455/
https://www.ncbi.nlm.nih.gov/pubmed/35990255
http://dx.doi.org/10.1016/j.lanepe.2022.100486

Ejemplares similares